External facilitation increases uptake of ActionADE
We tried out a helpful approach to assist in putting ActionADE into action in four VCH emergency departments.
A facilitator teamed up with local delivery teams to come up with plans to deal with challenges in making ActionADE work smoothly.
We put into practice eight activities. This included things like sharing stories from patients and holding educational meetings.
As a result, reporting of adverse drug events went up by 2.33 times.
Unveiling differences in adverse drug event reporting systems
We compared adverse drug event reports in two systems: the Patient Safety Learning System – Adverse Drug Reactions (PSLS-ADR) and ActionADE, aiming to find out the differences in the volume and the types of events recorded.
We analyzed 3,248 ADE reports, revealing 11.6% in PSLS-ADR and 88.4% in ActionADE
ActionADE captured 4- to 6-fold more comparable events than PSLS-ADR during the study period.
Common culprit drugs:
– PSLS-ADR: Iohexol, gadobutrol, and empagliflozin (46.2% of events).
– ActionADE: Hydrochlorothiazide, apixaban, and ramipril (11.6% of events).
Sharing Adverse Drug Event Insights for Safer Medication Practices
We analyzed 3,174 adverse drug event reports documented in ActionADE in four BC hospitals.
34% of patients presenting to hospitals with adverse drug events attempt to refill the culprit drug.
Community pharmacists did not re-dispense the culprit drug in 33.0% of cases when presented with information about the prior ADE.